Full name
GENESIS PHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
47 - Retail trade
58 - Publishing activities
63.12.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
68 - Real estate activities
73 - Advertising, market research and public relations
86.90.E - Healthcare
45.11.Z
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 2,4 | 3,1 | 1,3 | -58,2 |
Gross profit (loss) | 3,2 | 2,6 | 0,6 | -77,8 |
EBITDA | 2,5 | 2,9 | 1 | -66,7 |
Short time liabilities | 3,6 | 5,5 | 5,7 | 5,4 |
Other operating costs | 0,2 | 0,3 | 0,5 | 83 |
Equity capital | 3,5 | 4 | 4,3 | 9,4 |
Operating profit (EBIT) | 2,4 | 2,8 | 0,9 | -68,6 |
Assets | 7,1 | 9,4 | 10,1 | 7,1 |
Net profit (loss) | 3 | 2 | 0,4 | -82,2 |
Cash | 1,1 | 1,2 | 1,6 | 38,7 |
Net income from sale | 37,2 | 33,2 | 46,4 | 40 |
Liabilities and provisions for liabilities | 3,6 | 5,5 | 5,7 | 5,4 |
Working assets | 6,8 | 9,1 | 9,9 | 8,1 |
Other income costs | 0,2 | 0 | 0,1 | 1816,6 |
Depreciation | 0,1 | 0,1 | 0,1 | -0,8 |
% | % | % | p.p. | |
Profitability of capital | 84,9 | 51,4 | 8,4 | -43 |
Equity capital to total assets | 49,3 | 42,2 | 43,1 | 0,9 |
Gross profit margin | 8,6 | 7,8 | 1,2 | -6,6 |
EBITDA Margin | 6,8 | 8,7 | 2,1 | -6,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 35 | 60 | 45 | -15 |
Current financial liquidity indicator | 1.8731529712677002 | 1.6779742240905762 | 1.7205190658569336 | 0 |
Net dept to EBITDA | 0.5427326560020447 | 0.7495846748352051 | 0.9874632954597473 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane